DAta-driven personaLIzation of a digitAl Health Solution to Support Family Caregivers of Children With Chronic Conditions

Inclusion Criteria

• •Caregivers of children between 13 and 18 years who are diagnosed with obesity and undergoing treatment according to the approved label by AEMPS1 (adolescents with obesity aged 12 years and older with an initial BMI at the 95th percentile or greater for age and sex).
• •Families of children with obesity who have been under pharmacological treatment before screening. This includes treatment with any of the following medications orlistat, metformin, liraglutide, semaglutide.
• •Participants who are willing to join ACDP® for 10 months and can interact with a smartphone during that time.
• •The family is willing to complement the pharmacological obesity treatment with a digital intervention.
• •Participants (patients and their caregivers) must be willing to use wearables for the entire length of the study.
• •Parents previously using a wearable will agree not to use it during the length of the study, as their wearable account must be synched to the patient's device. Further, they may need to agree on changing the account data for height, weight, and gender in their Google account.